Last 48 quarters of trend data · Basic Materials · Agricultural Inputs
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Nutrien Ltd.'s quarterly P/E stands at 69.9x, down 87.4% year-over-year — suggesting improving earnings relative to price.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 13.26 | 69.87 | 12.86 | 15.61 | 5.82 | 554.35 | 48.64 | 330.08 | 16.32 | 42.43 | 39.12 | 102.93 | 16.40 |
| — | -87.4% | -73.6% | -95.3% | -64.3% | +1206.5% | +24.3% | +220.7% | -0.5% | +162.0% | +360.7% | +1351.8% | +436.0% | |
| P/S Ratio | 1.11 | 1.52 | 1.38 | 1.20 | 0.68 | 1.19 | 1.09 | 1.11 | 0.62 | 1.25 | 1.23 | 1.36 | 0.63 |
| — | +27.9% | +26.7% | +8.0% | +9.7% | -4.4% | -11.8% | -18.1% | -1.3% | -17.9% | -2.0% | -0.6% | -17.1% | |
| P/B Ratio | 1.21 | 1.44 | 1.18 | 1.13 | 1.13 | 1.01 | 0.90 | 0.95 | 1.00 | 1.08 | 1.11 | 1.21 | 1.15 |
| — | +42.3% | +30.5% | +19.2% | +12.9% | -6.1% | -18.4% | -21.6% | -12.9% | -26.6% | -24.4% | -29.3% | -30.4% | |
| P/FCF | 14.85 | — | 3.41 | — | 3.36 | — | 2.28 | — | 4.92 | — | 2.10 | — | 5.04 |
| — | — | +49.6% | — | -31.7% | — | +8.6% | — | -2.5% | — | -16.5% | — | -4.5% | |
| EV / EBITDA | 6.67 | 12.19 | 7.64 | 7.50 | 4.24 | 11.96 | 8.01 | 11.01 | 6.57 | 10.17 | 9.57 | 12.01 | 4.14 |
| — | +1.9% | -4.6% | -31.9% | -35.4% | +17.6% | -16.2% | -8.3% | +58.6% | +14.7% | +77.1% | +103.5% | +64.3% | |
| EV / EBIT | 10.73 | 29.56 | 11.24 | 13.18 | 5.70 | 42.18 | 20.54 | 48.49 | 11.13 | 23.87 | 37.41 | 29.23 | 9.35 |
| — | -29.9% | -45.3% | -72.8% | -48.7% | +76.7% | -45.1% | +65.9% | +19.0% | +76.3% | +395.2% | +348.0% | +236.4% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Nutrien Ltd.'s operating margin was 7.0% in Q1 2026, down 7.7 pp QoQ and up 2.6 pp YoY. The trailing four-quarter average of 13.0% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin expanded 5.2% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.0% | 27.2% | 35.4% | 32.7% | 30.4% | 25.9% | 31.1% | 28.0% | 28.7% | 28.5% | 31.2% | 28.9% | 27.2% |
| — | +5.2% | +13.6% | +16.6% | +6.1% | -9.3% | -0.3% | -2.9% | +5.5% | -9.0% | -19.1% | -27.5% | -34.3% | |
| Operating Margin | 14.5% | 7.0% | 14.8% | 13.3% | 17.1% | 4.4% | 9.3% | 5.0% | 8.3% | 7.8% | 8.2% | — | 17.1% |
| — | +58.6% | +59.1% | +169.1% | +105.4% | -43.0% | +12.5% | — | -51.3% | -49.4% | -64.3% | — | -49.9% | |
| Net Margin | 8.4% | 2.2% | 10.7% | 7.7% | 11.7% | 0.2% | 2.2% | 0.3% | 3.8% | 2.9% | 3.0% | 1.3% | 3.8% |
| — | +904.5% | +380.6% | +2194.8% | +208.6% | -92.6% | -26.7% | -74.7% | +0.4% | -68.6% | -79.4% | -93.1% | -84.8% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 9.3% | 0.5% | 2.3% | 1.8% | 5.0% | 0.0% | 0.5% | 0.1% | 1.5% | 0.6% | 0.7% | 0.3% | 1.7% |
| — | +1027.4% | +402.7% | +2442.5% | +223.2% | -92.8% | -33.1% | -75.8% | -11.4% | -71.8% | -84.1% | -95.1% | -87.7% | |
| ROA | 4.4% | 0.2% | 1.1% | 0.9% | 2.3% | 0.0% | 0.2% | 0.0% | 0.7% | 0.3% | 0.3% | 0.1% | 0.8% |
| — | +1057.1% | +411.8% | +2446.1% | +217.7% | -92.9% | -33.5% | -75.7% | -9.2% | -71.0% | -84.0% | -95.1% | -88.0% | |
| ROIC | 8.0% | 0.8% | 1.6% | 1.6% | 3.6% | 0.5% | 0.9% | 0.5% | 1.7% | 0.8% | 0.9% | — | 3.9% |
| — | +81.2% | +68.5% | +201.6% | +112.2% | -45.6% | +2.0% | — | -56.6% | -54.8% | -73.4% | — | -61.6% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Nutrien Ltd.'s Debt/EBITDA ratio is 13.8x, up from 9.4x last quarter — elevated, raising questions about debt serviceability.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.51 | 0.55 | 0.51 | 0.56 | 0.54 | 0.61 | 0.52 | 0.59 | 0.53 | 0.55 | 0.50 | 0.59 | 0.54 |
| — | -9.4% | -2.5% | -4.5% | +2.2% | +11.9% | +5.1% | -0.8% | -0.7% | -9.4% | +8.1% | +13.2% | +21.7% | |
| Debt / EBITDA | 2.03 | 13.76 | 9.40 | 10.11 | 5.69 | 18.45 | 12.07 | 17.10 | 9.35 | 13.86 | 12.18 | 15.99 | 5.35 |
| — | -25.4% | -22.1% | -40.9% | -39.1% | +33.1% | -0.9% | +6.9% | +74.7% | +30.4% | +130.7% | +185.1% | +149.2% | |
| Current Ratio | 1.34 | 1.24 | 1.34 | 1.41 | 1.33 | 1.22 | 1.15 | 1.27 | 1.26 | 1.15 | 1.17 | 1.25 | 1.26 |
| — | +1.5% | +16.7% | +11.3% | +5.2% | +5.8% | -2.1% | +1.6% | +0.3% | -2.3% | +2.2% | +8.4% | +3.8% | |
| Quick Ratio | 0.70 | 0.59 | 0.70 | 0.89 | 0.85 | 0.59 | 0.63 | 0.82 | 0.82 | 0.53 | 0.65 | 0.79 | 0.78 |
| — | +0.1% | +10.9% | +9.1% | +4.3% | +10.6% | -1.8% | +3.9% | +4.8% | -2.7% | +6.0% | +12.9% | +4.6% | |
| Interest Coverage | 5.44 | 2.41 | 5.03 | 4.75 | 11.50 | 1.26 | 2.18 | 1.07 | 5.21 | 2.34 | 1.21 | 1.87 | 5.53 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Deep dive into NTR consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying NTR stock.
Nutrien Ltd.'s current P/E is 13.3x. The average P/E over the last 4 quarters is 26.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Nutrien Ltd.'s current operating margin is 14.5%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Nutrien Ltd.'s business trajectory between earnings reports.